The 3D Cell Culture market is expected to expand by 2020. Experts gather at SMi’s event this February

3D Cell Culture is hitting the news this January with predictions for the global market, which was valued at US$ 586.1 Mn in 2014, being expected to expand at a CAGR of 29.1% to account for US$ 2,717.6 Mn by 2020*. Also, in the news: researchers in Korea have developed a technique that generates high yields of spheroid cultures with reproducible shapes and sizes using "lab-on-a-CD" technology, also known as centrifugal microfluidics**; and researchers in the U.S. have developed a 3D biomaterial scaffold that can promote much faster ex vivo expansion of functional T cells than currently available technologies***

SMi’s 3D Cell Culture Conference, 21 - 22nd February, will share the knowledge of the market and access to many clinical breakthroughs in research. Visit 3D Cell Culture website www.3D-cellculture.com/openpr

Benefits of attending the conference:
• Uncover the biology of human neurodevelopment diseases in 3D by merging cutting edge technologies in CRISPR editing and single cell sequencing
• Take a 3D biology approach to overcome challenges for cell based screening with exclusive insight into electrospun micro-scaffold based biology
• Develop strategies for optimising placement of cells in printing by identifying key developments in the overlap of 3D bioprinting and 3D cell culturing
• Identify new approaches to predictive substance testing through innovative case study insight into multi-organ-chip technology
• Benefit from an agenda tailored towards driving clinical development through ground breaking case studies on the Zika virus and tuberous sclerosis
• Adapt current microfluidic culture methods into large scale manufacturing

PLUS! A workshop on 3D BIOPRINTING AND OTHER BIOFABRICATION METHODS on 20th February will describe and discuss 3D bioprinting and other biofabrication approaches, answering emerging questions and challenges to these young and evolving fields.

Visit 3D Cell Culture website for further information and to book your place www.3D-cellculture.com/openpr

Sponsored by:
Bio-Techne | BioreclamationIVT | Integra Biosciences | Jellagen | Nexcelom

To sponsor or exhibit, contact Alia Malick on +44 (0)20 7827 6168

For delegate enquiries contact Kieran Ronaldson on +44 (0)20 7827 6744

*Industry Today, Published Jan 15th, 2018
**medicalphysicsweb, IOP Publishing, Published Jan 5, 2018
*** Genetic Engineering & Biotechnology News (GEN) Published January 16, 2018

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

1 Westminster Bridge Road

This release was published on openPR.